Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Transplantation. 2013 Sep 15;96(5):476–479. doi: 10.1097/TP.0b013e318299dc0e

Table 1.

Demographics of living donor kidney recipients in the Transplant Cancer Match Study by ABO compatibility status

ABOi ABOc
(entire cohort)
P-Value ABOc
(matched
controls)a
N=318 N=37,643 N=1,590
Age 0.4
  0–35 107 (33.7) 13,669 (36.3) 550 (34.6)
  36–50 99 (31.1) 12,392 (32.9) 467 (29.2)
  51–60 70 (22.0) 7,357 (19.5) 374 (23.5)
  >60 42 (13.2) 4,225 (11.2) 199 (12.5)
Gender 0.5
  Male 181 (56.9) 22,067 (58.6) 905 (56.9)
  Female 137 (43.1) 15,576 (41.4) 685 (43.1)
Raceb 0.02
  White 190 (60.1) 23,208 (62.1) 954 (60.0)
  African-American 61 (19.0) 5,238 (14.0) 307 (19.3)
  Hispanic/Other 65 (20.6) 8,941 (23.9) 329 (20.7)
Zero HLA Mismatchb 0.6
  No 274 (88.7) 32,377 (87.6) 1,410 (88.7)
  Yes 35 (11.3) 4,575 (12.4) 180 (11.3)
Retransplantation 0.03
  No 282 (88.7) 34,633 (92.0) 1,410 (88.7)
  Yes 36 (11.3) 3,010 (8.00) 180 (11.3)

ABOi = ABO incompatible; ABOc = ABO compatible. Cells show N (%).

a)

Matched 5 to 1 on age at transplantation (within five years), gender, race, zero HLA mismatch status, retransplantation, and year of transplant (within ten years) to ABOi recipients.

b)

Recipients do not sum to total because of missing data. P-values represent the comparison between ABOi patients and the entire ABOc cohort, using a chi-squared test.